Allergic contact dermatitis from essential oil in consumer products: Mode of uses and value of patch tests with an essential oil series. Results of a French study of the DAG (Dermato-Allergology group of the French Society of Dermatology).

68647-73-4 8000-28-0 (lavender absolute) 92201-50-8 Helichrysum italicum flower oil (90045-56-0 + 289-918-2) Ravintsara oil or Cinnamomum camphora oil allergic contact dermatitis essential oil fragrance lavender oil or Lavandula augustifolia patch tests tea tree oil or Melaleuca alternifolia leaf oil

Journal

Contact dermatitis
ISSN: 1600-0536
Titre abrégé: Contact Dermatitis
Pays: England
ID NLM: 7604950

Informations de publication

Date de publication:
Sep 2023
Historique:
revised: 21 06 2023
received: 07 04 2023
accepted: 23 06 2023
medline: 3 8 2023
pubmed: 5 7 2023
entrez: 5 7 2023
Statut: ppublish

Résumé

To analyse the clinical characteristics and sensitivity of an essential oil patch test series (EOS) in patients sensitized to their own essential oils (EOs). We analysed the clinical data and patch test results obtained with the European baseline series (BSE) and an EOS, as well as the mode of use of EOs, through a questionnaire included in the patient file. The study included 42 patients (79% women, average age 50 years) with allergic contact dermatitis (ACD), 8 patients required hospitalization. All patients were sensitized to the EO they used, primarily lavender (Lavandula augustifolia, 8000-28-0), tea tree (Melaleuca alternifolia leaf oil, 68647-73-4), ravintsara (Cinnamomum camphora oil, 92201-50-8), and 2 cases were attributed to helichrysum (helichrysum italicum flower absolute, 90045-56-0). 71% had positive patch tests to fragrance mix I or II, 9 only to the EOS and 4 only with their personal EO. Interestingly, 40% of patients did not spontaneously mention the use of EOs, and only 33% received advice on their use at the time of purchase. Patch tests with the BSE, limonene and linalool HP, and oxidized tea tree oil is sufficient to detect most EO-sensitized patients. The most important is to test the patient's own used EOs.

Identifiants

pubmed: 37403438
doi: 10.1111/cod.14377
doi:

Substances chimiques

Oils, Volatile 0
Tea Tree Oil 68647-73-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

190-197

Informations de copyright

© 2023 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd.

Références

Geier J, Schubert S, Reich K, et al. Contact sensitization to essential oils: IVDK data of the years 2010-2019. Contact Dermatitis. 2022;87(1):71-80.
de Groot AC, Schmidt E. Essential oils, part IV: contact allergy. Dermat Contact Atopic Occup Drug. 2016;27(4):170-175.
Posadzki P, Alotaibi A, Ernst E. Adverse effects of aromatherapy: a systematic review of case reports and case series. Int J Risk Saf Med. 2012;24(3):147-161.
Sabroe RA, Holden CR, Gawkrodger DJ. Contact allergy to essential oils cannot always be predicted from allergy to fragrance markers in the baseline series. Contact Dermatitis. 2016;74(4):236-241.
Wilkinson M, Gonçalo M, Aerts O, et al. The European baseline series and recommended additions: 2019. Contact Dermatitis. 2019;80(1):1-4.
Dornic N, Ficheux AS, Roudot AC. Qualitative and quantitative composition of essential oils: a literature-based database on contact allergens used for safety assessment. Regul Toxicol Pharmacol. 2016;80:226-232.
de Groot AC, Schmidt E. Essential Oils. Contact Allergy and Chemical Composition. CRC Press; 2016:1058.
Khanna M, Qasem K, Sasseville D. Allergic contact dermatitis to tea tree oil with erythema multiforme-like id reaction. Am J Contact Dermat. 2000;11(4):238-242.
Robinson A, McGrail MR. Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med. 2004;12(2-3):90-98.
de Groot AC, Schmidt E. Tea tree oil: contact allergy and chemical composition. Contact Dermatitis. 2016;75(3):129-143.
Uter W, Schmidt E, Geier J, Lessmann H, Schnuch A, Frosch P. Contact allergy to essential oils: current patch test results (2000-2008) from the Information Network of Departments of Dermatology (IVDK). Contact Dermatitis. 2010;63(5):277-283.
Hagvall L, Christensson JB. Patch testing with main sensitizers does not detect all cases of contact allergy to oxidized lavender oil. Acta Derm Venereol. 2016;96(5):679-683.
de Groot A, Schmidt E. Essential oils, part V: peppermint oil, lavender oil, and lemongrass oil. Dermatitis. 2016;27(6):325-332.
Warshaw EM, Zug KA, Belsito DV, et al. Positive patch test reactions to essential oils in consecutive patients from North America and Central Europe. Dermatitis. 2017;28(4):246-252.
Poudel DK, Rokaya A, Ojha PK, et al. The chemical profiling of essential oils from different tissues of Cinnamomum camphora L. and their antimicrobial activities. Molecules. 2021;26(17):5132.
Foti C, Guida S, Antelmi A, Romita P, Corazza M. Allergic contact dermatitis caused by Helichrysum italicum contained in an emollient cream. Contact Dermatitis. 2013;69(1):62-63.
Zheljazkov VD, Semerdjieva I, Yankova-Tsvetkova E, et al. Chemical profile and antimicrobial activity of the essential oils of Helichrysum arenarium (L) Moench and Helichrysum italicum (Roth.) G. Don. Plants (Basel). 2022;11(7):951.
Kunc N, Frlan A, Baričevič D, Kočevar Glavač N, Kokalj Ladan M. Essential oil and hydrosol composition of immortelle (Helichrysum italicum). Plants (Basel). 2022;11(19):2573.
Uter W, Johansen JD, Börje A, et al. Categorization of fragrance contact allergens for prioritization of preventive measures: clinical and experimental data and consideration of structure-activity relationships. Contact Dermatitis. 2013;69(4):196-230.
Dornic N, Ficheux AS, Roudot AC, Saboureau D, Ezzedine K. Usage patterns of aromatherapy among the French general population: a descriptive study focusing on dermal exposure. Regul Toxicol Pharmacol. 2016;76:87-93.
Xiao J, Nakai S. Usage patterns of aromatherapy essential oil among Chinese consumers. PLoS One. 2022;17(8):e0272031.
Bråred Christensson J, Forsström P, Wennberg A-M, Karlberg A-T, Matura M. Air oxidation increases skin irritation from fragrance terpenes. Contact Dermatitis. 2009;60(1):32-40.
Nardelli A, D'Hooghe E, Drieghe J, Dooms M, Goossens A. Allergic contact dermatitis from fragrance components in specific topical pharmaceutical products in Belgium. Contact Dermatitis. 2009;60(6):303-313.
Matura M, Sköld M, Börje A, et al. Selected oxidized fragrance terpenes are common contact allergens. Contact Dermatitis. 2005;52(6):320-328.

Auteurs

Annick Barbaud (A)

Dermatology and Allergy Department, Médecine Sorbonne Université, Service de dermatologie et d'allergologie, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Tenon Hospital, AP-HP, Paris, France.
Department of Dermatology and Allergology, INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, AP-HP Sorbonne Universite, Tenon Hopital, Paris, France.

Flore Kurihara (F)

Dermatology and Allergy Department, Médecine Sorbonne Université, Service de dermatologie et d'allergologie, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Tenon Hospital, AP-HP, Paris, France.

Nadia Raison-Peyron (N)

Department of Dermatology, CHU Montpellier, Montpellier, France.

Brigitte Milpied (B)

Department of Dermatology, Hôpital St André, Bordeaux, France.

Aude Valois (A)

Department of Dermatology, HIA, Toulon, France.

Haudrey Assier (H)

Department of Dermatology, CHU Henri-Mondor, Créteil, France.

Cécile Morice (C)

Department of Dermatology, CHU Caen, Caen, France.

Jean Romain Manciet (JR)

Department of Dermatology, CHU Saint-Louis, Paris, France.

Gwendeline Gener (G)

Department of Dermatology, CHU Henri-Mondor, Créteil, France.

Françoise Giordano-Labadie (F)

Department of Dermatology, Hôpital Larrey, CHU Toulouse, Toulouse, France.

Pierre Marcant (P)

Department of Dermatology, CHU Lille, Lille, France.

Claire Bernier (C)

Department of Dermatology, Nantes University Hospital, Nantes, France.

Emmanuelle Amsler (E)

Dermatology and Allergy Department, Médecine Sorbonne Université, Service de dermatologie et d'allergologie, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Tenon Hospital, AP-HP, Paris, France.

Marie Noelle Crepy (MN)

Department of Occupational and Environmental Diseases, Hotel-Dieu Hospital, Paris, France.

Florence Tetart (F)

Department of Dermatology, CHU Rouen, Rouen, France.

Angèle Soria (A)

Dermatology and Allergy Department, Médecine Sorbonne Université, Service de dermatologie et d'allergologie, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Tenon Hospital, AP-HP, Paris, France.

Marie-Christine Ferrier le Bouëdec (MF)

Department of Dermatology, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH